Comoros vs Ecuador: HIV-positive TB patients on ART (antiretroviral therapy)
Comoros
100.0%
in 2023
Ecuador
100.0%
in 2024
Comoros rank
1st
Ecuador rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Comoros
- Ecuador
How they compare
Comoros currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
The two have swapped places 5 times across 9 shared years of data; in 2012 it was Ecuador ahead.
Comoros ranks 1st and Ecuador ranks 1st of 144 countries.
Across the 2 decades both report, Comoros averaged higher in 1 and Ecuador in 1.
Head to head by decade
| Decade | Comoros | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 98.4% | 1.6% | Comoros |
| 2020s | 91.8% | 92.2% | 0.5% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Comoros or Ecuador?
- Comoros, at 100.0% against 100.0% in Ecuador as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Comoros and Ecuador?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and Ecuador?
- 9 years are reported by both, from 2012 to 2023.
- How do Comoros and Ecuador rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Comoros ranks 1st and Ecuador ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.